EUVIMEDEUVIMED entdecken
Crossref

GCN5 ‐Mediated Lactylation of YY1 Promotes Diabetic Cardiomyopathy by Activating Twist1‐Dependent EndMT

Jingjing Liu, Zhiwen Zhang iD, Qingbo Shi, Zhuocheng Shi, Yang Gao, Quan Guo, Yushuo Gu, Chaowei Zhang, Bingchuan Geng, Haitao Yang, Muwei Li iD, Chuanyu Gao iD

The FASEB Journal · 2026

DOI: 10.1096/fj.202601430r ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, 2026. Verfasst von Jingjing Liu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Zhengzhou University People's Hospital, Fuwai Central China Cardiovascular Hospital, Zhengzhou, Henan Province, China. Hauptthemen laut MEDLINE: YY1 Transcription Factor, Endothelial-Mesenchymal Transition, Twist-Related Protein 1, Diabetic Cardiomyopathies. Die Arbeit nennt 37 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Henan Cardiovascular Disease Center (Central China Subcenter of National Center for Cardiovascular Diseases).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Endothelial‐to‐mesenchymal transition (EndMT) plays a pivotal role in fibroblast proliferation and cardiac fibrosis during diabetic cardiomyopathy (DCM) development, yet its underlying regulatory mechanisms remain unknown. The objective of this study is to investigate the role of general control non‐repressed 5 protein (GCN5) and its mediated protein lactylation in regulating EndMT during DCM progression. We combined in vitro (high glucose (HG)‐treated HUVECs) and in vivo (high‐fat diet (HFD)/streptozotocin (STZ)‐induced DCM mice) models with endothelial‐specific GCN5‐knockout mice. Pathological changes and fibrosis in cardiac tissue were assessed using HE staining and Masson staining, respectively. Cell migration was determined using wound healing and Transwell assays. Co‐IP assay was employed to detect YY1 lactylation, as well as the interaction between YY1 and GCN5. ChIP and dual‐luciferase reporter assays were employed to analyze the binding relationship between YY1 and the Twist1 promoter. GCN5 was upregulated in diabetic hearts and endothelial cells, and its knockdown reduced Twist1‐dependent EndMT in HG‐treated HUVECs. Mechanistically, GCN5 catalyzed YY1 lactylation at K203, which enhanced YY1 phosphorylation at Thr398, activating Twist1 transcription. GCN5 knockdown reversed the promoting effect of wildtype YY1 overexpression on HG‐induced EndMT but didn't affect the effect of mutant YY1 overexpression on EndMT. Endothelial‐specific GCN5 deletion reversed HFD/STZ‐induced cardiac dysfunction and fibrosis in mice by inhibiting Twist1‐dependent EndMT. GCN5 enhanced Twist1 transcription by promoting lactylation of YY1 at K203 and its phosphorylation at Thr398, thereby increasing EndMT in DCM. This GCN5‐YY1‐Twist1 axis may offer novel therapeutic targets for DCM management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

YY1 Transcription FactorEndothelial-Mesenchymal TransitionTwist-Related Protein 1Diabetic CardiomyopathiesNuclear ProteinsAnimalsMiceHumansMaleMice, KnockoutMice, Inbred C57BLp300-CBP-Associated FactorDiabetes Mellitus, ExperimentalHuman Umbilical Vein Endothelial Cells

Stichwörter der Autor:innen

GCN5Twist1YY1diabetic cardiomyopathyendothelial‐to‐mesenchymal transitionlactylation

Substanzen

YY1 Transcription FactorYy1 protein, mouseTwist-Related Protein 1Nuclear Proteinsp300-CBP-Associated FactorTwist1 protein, mouseYY1 protein, humanTWIST1 protein, human

Autor:innen und Institutionen

  • Department of Cardiology, Zhengzhou University People's Hospital, Fuwai Central China Cardiovascular Hospital, Zhengzhou, Henan Province, China.
  • Central China Subcenter of National Center for Cardiovascular Diseases, Henan Cardiovascular Disease Center, Zhengzhou, Henan Province, China.
  • Henan Microcirculation Disease Engineering Research Center, Zhengzhou, Henan Province, China.

ORCID-Profile: Zhiwen Zhang, Muwei Li, Chuanyu Gao

Förderung

  • National Natural Science Foundation of China
  • Henan Cardiovascular Disease Center (Central China Subcenter of National Center for Cardiovascular Diseases)

Zitieren

APA

Liu, J., Zhang, Z., Shi, Q., Shi, Z., Gao, Y., Guo, Q., Gu, Y., Zhang, C., Geng, B., Yang, H., Li, M., & Gao, C. (2026). GCN5 ‐Mediated Lactylation of YY1 Promotes Diabetic Cardiomyopathy by Activating Twist1‐Dependent EndMT. The FASEB Journal. https://doi.org/10.1096/fj.202601430r

Vancouver

Liu J, Zhang Z, Shi Q, Shi Z, Gao Y, Guo Q, et al. GCN5 ‐Mediated Lactylation of YY1 Promotes Diabetic Cardiomyopathy by Activating Twist1‐Dependent EndMT. The FASEB Journal. 2026. doi:10.1096/fj.202601430r

BibTeX
@article{Liu2026,
  author = {Liu, Jingjing and Zhang, Zhiwen and Shi, Qingbo and Shi, Zhuocheng and Gao, Yang and Guo, Quan and Gu, Yushuo and Zhang, Chaowei and Geng, Bingchuan and Yang, Haitao and Li, Muwei and Gao, Chuanyu},
  title = {GCN5 ‐Mediated Lactylation of YY1 Promotes Diabetic Cardiomyopathy by Activating Twist1‐Dependent EndMT},
  journal = {The FASEB Journal},
  year = {2026},
  doi = {10.1096/fj.202601430r}
}
Kostenlos starten →